Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.
about
High-resolution structures of bacterially expressed soluble human CD59Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrierBiomedical applications of glycosylphosphatidylinositol-anchored proteinsStructural Basis for Recognition of the Pore-Forming Toxin Intermedilysin by Human Complement Receptor CD59Complement-targeted therapeuticsNew insights of an old defense system: structure, function, and clinical relevance of the complement system.Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria.Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report.Anticomplement therapy.Drug delivery by red blood cells: vascular carriers designed by mother nature.Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria.Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications.Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.High sensitivity 8-color flow cytometry assay for paroxysmal nocturnal hemoglobinuria granulocyte and monocyte detections.
P2860
Q24657819-55ABE788-7DF6-420A-85A5-28EF048CACE4Q26801300-6C067B61-6846-406D-9607-19AEB69777AAQ27468625-ABBC90BC-E06C-4C01-9790-81E4C337FE3AQ27678091-9E9301A7-C92C-4026-8813-D15137205D43Q34255011-6F844AB3-EAE6-4157-AA60-C54B944EC8DCQ34699496-F6445CC0-6B79-4956-AE0C-3B8C9CE750CEQ36780187-AE132155-FFF0-4A0B-BBBA-6D7EAD46068DQ37082416-8EDCD8D6-E903-4105-AD21-F6D7E926B5E9Q37307880-9AD6C0F1-A4DF-4BEC-8AE8-140C41B900DCQ37700751-D8F99F00-B3DA-4F1E-9F33-912B5765E42DQ37810103-857D43B4-064F-4D92-BE44-773DD0AB2D74Q38747312-6BAD24CC-F276-4F7B-B990-4B7D516FDD46Q38760096-A6EB4BCB-4D0A-4605-A5F4-49E7851EA41FQ42036462-B5B11DCF-392B-44B2-8644-D7D887658196Q55089377-771DFBC4-AA39-45EF-BB52-919E9E84A066
P2860
Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@ast
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@en
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@en-gb
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@nl
type
label
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@ast
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@en
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@en-gb
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@nl
prefLabel
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@ast
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@en
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@en-gb
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@nl
P2093
P1433
P1476
Protection of erythrocytes fro ...... a new approach to PNH therapy.
@en
P2093
Anita Hill
Dirk Esser
Geoffrey P Smith
Jennifer White
Matthew J Cullen
Paula Kareclas
Richard A G Smith
Rodney G Oldroyd
Seán Gallagher
Simon H Ridley
P304
P356
10.1182/BLOOD-2005-02-0782
P407
P577
2005-12-01T00:00:00Z